P477: COMBINATION OF DIFFERENT IMMUNOTHERAPEUTIC DRUGS ENHANCES SPECIFIC T CELL IMMUNE RESPONSES AGAINST LEUKEMIC CELLS AND LEUKEMIC PROGENITOR/STEM CELLS IN ACUTE MYELOID LEUKEMIA
Main Authors: | Jochen Greiner, Patrick Schuler, Hubert Schrezenmeier, Susanne Hofmann, Marlies Götz |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Wiley
2023-08-01
|
丛编: | HemaSphere |
在线阅读: | http://journals.lww.com/10.1097/01.HS9.0000968816.72631.a8 |
相似书籍
-
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
由: Barbara Depreter, et al.
出版: (2020-05-01) -
Leukemic stem cells and therapy resistance in acute myeloid leukemia
由: Patrick Stelmach, et al.
出版: (2023-02-01) -
Characterising the cell biology of leukemic stem cells in acute myeloid leukemia.
由: Cornforth, TV
出版: (2013) -
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
由: Craddock, C, et al.
出版: (2013) -
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
由: Craddock, C, et al.
出版: (2013)